HL7 Terminology (THO)
3.1.5 - Continuous Process Integration (ci build) International flag

HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This is not an authorized publication; it is the continuous build for version 3.1.5). This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions

ValueSet: LogicalObservationIdentifierNamesAndCodes

Official URL: http://terminology.hl7.org/ValueSet/v3-LogicalObservationIdentifierNamesAndCodes Version: 2.0.0
Active as of 2014-03-26 Computable Name: LogicalObservationIdentifierNamesAndCodes
Other Identifiers: : urn:oid:2.16.840.1.113883.1.11.16492

The LOINC database provides a set of universal names and ID codes for identifying laboratory and clinical test results. The purpose is to facilitate the exchange and pooling of results, such as blood hemoglobin, serum potassium, or vital signs, for clinical care, outcomes management, and research. The LOINC codes are not intended to transmit all possible information about a test or observation. They are only intended to identify the test result or clinical observation. http://www.regenstrief.org/LOINC/LOINC.htm

References

Logical Definition (CLD)

 

Expansion

This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown

Expansion based on Loinc v2.72

All codes in this table are from the system http://loinc.org

CodeDisplay - English (English, en)
  1-8Acyclovir [Susceptibility]
  10-9Amdinocillin [Susceptibility] by Serum bactericidal titer
  100-8Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)
  1000-9DBG Ab [Presence] in Serum or Plasma from Blood product unit
  10000-8R wave duration in lead AVR
  100002-5Specimen care is maintained
  100003-3Team communication is maintained throughout care
  100004-1Demonstrates knowledge of the expected psychosocial responses to the procedure
  100005-8Demonstrates knowledge of nutritional management related to the procedure
  100006-6Demonstrates knowledge of medication management
  100007-4Demonstrates knowledge of pain management
  100008-2Demonstrates knowledge of wound management
  100009-0Demonstrates knowledge of the procedure and expected results
  10001-6R wave duration in lead I
  100010-8No injury related to procedure equipment, medical supplies, or instrumentation
  100011-6No injury related to an electrical source
  100012-4Participates in decisions affecting the patient's plan of care
  100013-2Participates in the discharge process
  100014-0Psychosocial health is maintained at or improved from baseline
  100015-7No injury related to positioning due to care or procedure
  100016-5No injury related to a laser source
  100017-3Perioperative nursing data set outcomes panel [PNDS]
  100018-1Hospice care Note
  100019-9ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  10002-4R wave duration in lead II
  100020-7GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100021-5GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100022-3IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100023-1IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100024-9SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100025-6SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100026-4MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100027-2SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100028-0FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100029-8Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method
  10003-2R wave duration in lead III
  100030-6Axis I: Temporal aspects score [Mainz Pain Staging System]
  100031-4Axis II: Spatial aspects score [Mainz Pain Staging System]
  100032-2Axis III: Drug taking behavior score [Mainz Pain Staging System]
  100033-0Axis IV: Utilization of the health care system score [Mainz Pain Staging System]
  100034-8Provider of automated external defibrillator use
  100035-5Exam finding location of Chest
  100036-3Exam finding location of Lung
  100037-1Patient contact disposition EMS unit
  100038-9Patient evaluation disposition EMS unit
  100039-7Crew disposition for patient care EMS unit
  10004-0R wave duration in lead V1
  100040-5Patient transport disposition EMS unit
  100041-3Aminoglycoside [Susceptibility]
  100042-1Atovaquone [Susceptibility]
  100043-9Azithromycin+Ethambutol [Susceptibility]
  100044-7Cefcapene [Susceptibility]
  100045-4Cefozopran [Susceptibility]
  100046-2Cefquinome [Susceptibility]
  100047-0Cefteram [Susceptibility]
  100048-8Clarithromycin+Ethambutol [Susceptibility]
  100049-6Eravacycline [Susceptibility]
  10005-7R wave duration in lead V2
  100050-4Erythromycin+Ethambutol [Susceptibility]
  100051-2Ethambutol+rifAMPin [Susceptibility]
  100052-0Flomoxef [Susceptibility]
  100053-8Fluoroquinolone [Susceptibility]
  100054-6Gamithromycin [Susceptibility]
  100055-3Optochin [Susceptibility]
  100056-1Panipenem [Susceptibility]
  100057-9Prothionamide [Susceptibility]
  100058-7Prulifloxacin [Susceptibility]
  100059-5Rifapentine [Susceptibility]
  10006-5R wave duration in lead V3
  100060-3Tildipirosin [Susceptibility]
  100061-1Tosufloxacin [Susceptibility]
  100062-9Standard Dermatology Outcome Measures panel
  100063-7Primary skin concern
  100064-5Itch severity Reporting Period - Reported
  100065-2Satisfied with treatment
  100066-0Specular microscopy panel
  100067-8Eye Image magnification
  100068-6Right eye Fixation point [Angle]
  100069-4Left eye Fixation point [Angle]
  10007-3R wave duration in lead V4
  100070-2Right cornea Cell density
  100071-0Left cornea Cell density
  100072-8Right cornea Coefficient of variation
  100073-6Left cornea Coefficient of variation
  100074-4Right cornea Hexagonality
  100075-1Left cornea Hexagonality
  100076-9Right cornea Endothelial cells counted
  100077-7Left cornea Endothelial cells counted
  100078-5Right cornea Endothelial cell area.min
  100079-3Left cornea Endothelial cell area.min
  10008-1R wave duration in lead V5
  100080-1Right cornea Endothelial cell area.max
  100081-9Left cornea Endothelial cell area.max
  100082-7Right cornea Endothelial cell area.mean
  100083-5Left cornea Endothelial cell area.mean
  100084-3Right cornea Cell area.standard deviation
  100085-0Left cornea Cell area.standard deviation
  100086-8Right cornea Type of Analysis method by Specular microscopy
  100087-6Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot
  100088-4Taenia solium larva Ab bands panel - Serum by Immunoblot
  100089-2Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot
  10009-9R wave duration in lead V6
  100090-0Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot
  100091-8Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay
  100092-6Trypanosoma cruzi Ab bands panel - Serum by Immunoblot
  100093-4Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot
  100094-2Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot
  100095-9Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot
  100096-7Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot
  100097-5Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot
  100098-3Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot
  100099-1Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot
  1001-7DBG Ab [Presence] in Serum or Plasma from Donor
  10010-7R' wave amplitude in lead AVF
  100100-7Fasciola sp IgG Ab [Presence] in Serum by Immunoassay
  100101-5Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot
  100102-3Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot
  100103-1Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot
  100104-9Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot
  100105-6Filaria IgG and IgM panel - Serum
  100106-4Filaria IgG Ab [Presence] in Serum by Immunoassay
  100107-2Leishmania sp IgG Ab [Presence] in Serum by Immunoassay
  100108-0Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay
  100109-8Leishmania sp Ab bands panel - Serum by Immunoblot
  10011-5R' wave amplitude in lead AVL
  100110-6Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot
  100111-4Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot
  100112-2Fasciola sp Ab bands panel - Serum by Immunoblot
  100113-0Helicobacter pylori Ab panel - Serum
  100114-8Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot
  100115-5Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot
  100116-3Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot
  100117-1Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot
  100118-9Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot
  100119-7Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot
  10012-3R' wave amplitude in lead AVR
  100120-5Chlamydia trachomatis Ab panel - Serum
  100121-3Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay
  100122-1Chlamydophila pneumoniae Ab panel - Serum
  100123-9Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay
  100124-7Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay
  100125-4Chlamydophila psittaci Ab panel - Serum
  100126-2Bordetella pertussis Ab.IgG panel - Serum
  100127-0Campylobacter sp Ab panel - Serum
  100128-8Cryptococcus sp Ag panel - Serum
  100129-6Schistosoma sp Ab [Titer] in Serum by Hemagglutination
  10013-1R' wave amplitude in lead I
  100130-4Schistosoma mansoni Ab [Presence] in Serum by Immunoblot
  100131-2Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot
  100132-0Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot
  100133-8Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot
  100134-6Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot
  100135-3Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot
  100136-1Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot
  100137-9Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot
  100138-7Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot
  100139-5Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot
  10014-9R' wave amplitude in lead II
  100140-3Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot
  100141-1Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot
  100142-9Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot
  100143-7Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot
  100144-5Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot
  100145-2Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot
  100146-0Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot
  100147-8Toxoplasma gondii Ab bands panel - Serum by Immunoblot
  100148-6Schistosoma sp Ab bands panel - Serum by Immunoblot
  100149-46-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma
  10015-6R' wave amplitude in lead III
  100150-26(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma
  100151-06-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma
  100152-86-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine
  100153-66(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine
  100154-4Specimen collection supervision level
  100155-1Left cornea Type of Analysis method by Specular microscopy
  100156-9SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection
  100157-7SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing
  10016-4R' wave amplitude in lead V1
  10017-2R' wave amplitude in lead V2
  10018-0R' wave amplitude in lead V3
  10019-8R' wave amplitude in lead V4
  1002-5DBG Ab [Presence] in Serum or Plasma
  10020-6R' wave amplitude in lead V5
  10021-4R' wave amplitude in lead V6
  10022-2R' wave duration in lead AVF
  10023-0R' wave duration in lead AVL
  10024-8R' wave duration in lead AVR
  10025-5R' wave duration in lead I
  10026-3R' wave duration in lead II
  10027-1R' wave duration in lead III
  10028-9R' wave duration in lead V1
  10029-7R' wave duration in lead V2
  1003-3Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma
  10030-5R' wave duration in lead V3
  10031-3R' wave duration in lead V4
  10032-1R' wave duration in lead V5
  10033-9R' wave duration in lead V6
  10034-7S wave amplitude in lead AVF
  10035-4S wave amplitude in lead AVL
  10036-2S wave amplitude in lead AVR
  10037-0S wave amplitude in lead I
  10038-8S wave amplitude in lead II
  10039-6S wave amplitude in lead III
  1004-1Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells
  10040-4S wave amplitude in lead V1
  10041-2S wave amplitude in lead V2
  10042-0S wave amplitude in lead V3
  10043-8S wave amplitude in lead V4
  10044-6S wave amplitude in lead V5
  10045-3S wave amplitude in lead V6
  10046-1S wave duration in lead AVF
  10047-9S wave duration in lead AVL
  10048-7S wave duration in lead AVR
  10049-5S wave duration in lead I
  1005-8Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma
  10050-3S wave duration in lead II
  10051-1S wave duration in lead III
  10052-9S wave duration in lead V1
  10053-7S wave duration in lead V2
  10054-5S wave duration in lead V3
  10055-2S wave duration in lead V4
  10056-0S wave duration in lead V5
  10057-8S wave duration in lead V6
  10058-6S' wave amplitude in lead AVF
  10059-4S' wave amplitude in lead AVL
  1006-6Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells
  10060-2S' wave amplitude in lead AVR
  10061-0S' wave amplitude in lead I
  10062-8S' wave amplitude in lead II
  10063-6S' wave amplitude in lead III
  10064-4S' wave amplitude in lead V1
  10065-1S' wave amplitude in lead V2
  10066-9S' wave amplitude in lead V3
  10067-7S' wave amplitude in lead V4
  10068-5S' wave amplitude in lead V5
  10069-3S' wave amplitude in lead V6
  1007-4Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
  10070-1S' wave duration in lead AVF
  10071-9S' wave duration in lead AVL
  10072-7S' wave duration in lead AVR
  10073-5S' wave duration in lead I
  10074-3S' wave duration in lead II
  10075-0S' wave duration in lead III
  10076-8S' wave duration in lead V1
  10077-6S' wave duration in lead V2
  10078-4S' wave duration in lead V3
  10079-2S' wave duration in lead V4
  1008-2Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma
  10080-0S' wave duration in lead V5
  10081-8S' wave duration in lead V6
  10082-6ST initial amplitude 6 ms in lead AVF
  10083-4ST initial amplitude 6 ms in lead AVL
  10084-2ST initial amplitude 6 ms in lead AVR
  10085-9ST initial amplitude 6 ms in lead I
  10086-7ST initial amplitude 6 ms in lead II
  10087-5ST initial amplitude 6 ms in lead III
  10088-3ST initial amplitude 6 ms in lead V1
  10089-1ST initial amplitude 6 ms in lead V2
  1009-0Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells
  10090-9ST initial amplitude 6 ms in lead V3
  10091-7ST initial amplitude 6 ms in lead V4
  10092-5ST initial amplitude 6 ms in lead V5
  10093-3ST initial amplitude 6 ms in lead V6
  10094-1ST slope in lead AVF
  10095-8ST slope in lead AVL
  10096-6ST slope in lead AVR
  10097-4ST slope in lead I
  10098-2ST slope in lead II
  10099-0ST slope in lead III
  101-6Cefoperazone [Susceptibility] by Disk diffusion (KB)
  1010-8E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit
  10100-6ST slope in lead V1
  10101-4ST slope in lead V2
  10102-2ST slope in lead V3
  10103-0ST slope in lead V4
  10104-8ST slope in lead V5
  10105-5ST slope in lead V6
  10106-3ST wave end displacement in lead AVF
  10107-1ST wave end displacement in lead AVL
  10108-9ST wave end displacement in lead AVR
  10109-7ST wave end displacement in lead I
  1011-6E sup(w) Ab [Presence] in Serum or Plasma from Donor
  10110-5ST wave end displacement in lead II
  10111-3ST wave end displacement in lead III
  10112-1ST wave end displacement in lead V1
  10113-9ST wave end displacement in lead V2
  10114-7ST wave end displacement in lead V3
  10115-4ST wave end displacement in lead V4
  10116-2ST wave end displacement in lead V5
  10117-0ST wave end displacement in lead V6
  10118-8ST wave mid displacement in lead AVF
  10119-6ST wave mid displacement in lead AVL
  1012-4E sup(w) Ab [Presence] in Serum or Plasma
  10120-4ST wave mid displacement in lead AVR
  10121-2ST wave mid displacement in lead I
  10122-0ST wave mid displacement in lead II
  10123-8ST wave mid displacement in lead III
  10124-6ST wave mid displacement in lead V1
  10125-3ST wave mid displacement in lead V2
  10126-1ST wave mid displacement in lead V3
  10127-9ST wave mid displacement in lead V4
  10128-7ST wave mid displacement in lead V5
  10129-5ST wave mid displacement in lead V6
  1013-2E sup(w) Ag [Presence] on Red Blood Cells from Blood product unit
  10130-3T' wave amplitude in lead AVF
  10131-1T' wave amplitude in lead AVL
  10132-9T' wave amplitude in lead AVR
  10133-7T' wave amplitude in lead I
  10134-5T' wave amplitude in lead II
  10135-2T' wave amplitude in lead III
  10136-0T' wave amplitude in lead V1
  10137-8T' wave amplitude in lead V2
  10138-6T' wave amplitude in lead V3
  10139-4T' wave amplitude in lead V4
  1014-0E sup(w) Ag [Presence] on Red Blood Cells from Donor
  10140-2T' wave amplitude in lead V5
  10141-0T' wave amplitude in lead V6
  10142-8T wave amplitude in lead AVF
  10143-6T wave amplitude in lead AVL
  10144-4T wave amplitude in lead AVR
  10145-1T wave amplitude in lead I
  10146-9T wave amplitude in lead II
  10147-7T wave amplitude in lead III
  10148-5T wave amplitude in lead V1
  10149-3T wave amplitude in lead V2
  1015-7E sup(w) Ag [Presence] on Red Blood Cells
  10150-1T wave amplitude in lead V3
  10151-9T wave amplitude in lead V4
  10152-7T wave amplitude in lead V5
  10153-5T wave amplitude in lead V6
  10154-3Chief complaint Narrative - Reported
  10155-0History of allergies, reported
  10156-8History of Childhood diseases Narrative
  10157-6History of family member diseases Narrative
  10158-4History of Functional status Narrative
  10159-2History of Industrial exposure Narrative
  1016-5E Ab [Presence] in Serum or Plasma from Blood product unit
  10160-0History of Medication use Narrative
  10161-8History of Occupational exposure Narrative
  10162-6History of pregnancies Narrative
  10163-4History of pregnancies
  10164-2History of Present illness Narrative
  10165-9Deprecated History of psychiatric symptoms and diseases Narrative
  10166-7History of Social function Narrative
  10167-5History of Surgical procedures Narrative
  10168-3History of Cardiovascular system disorders Narrative
  10169-1History of Ear disorders Narrative
  1017-3E Ab [Presence] in Serum or Plasma from Donor
  10170-9History of Endocrine system disorders Narrative
  10171-7History of Eyes disorders Narrative
  10172-5History of Hematologic system disorders Narrative
  10173-3History of Musculoskeletal system disorders Narrative
  10174-1History of Nose disorders Narrative
  10175-8History of Oral cavity disorders Narrative
  10176-6History of Reproductive system disorders Narrative
  10177-4History of Respiratory system disorders Narrative
  10178-2History of Skin disorders Narrative
  10179-0History of Throat and Neck disorders Narrative
  1018-1E Ab [Presence] in Serum or Plasma
  10180-8History of Throat and Neck disorders
  10181-6History of Urinary tract disorders Narrative
  10182-4History of Travel Narrative
  10183-2Hospital discharge medications Narrative
  10184-0Hospital discharge physical findings Narrative
  10185-7Hospital discharge procedures Narrative
  10186-5Identifying information Narrative Observed
  10187-3Review of systems Narrative - Reported
  10188-1Review of systems overview Narrative - Reported
  10189-9Review of systems overview - Reported
  1019-9E Ag [Presence] on Red Blood Cells from Blood product unit
  10190-7Mental status Narrative
  10191-5Physical findings of Abdomen Narrative
  10192-3Physical findings of Back Narrative
  10193-1Physical findings of Breasts Narrative
  10194-9Physical findings of Neurologic deep tendon reflexes Narrative
  10195-6Physical findings of Ear Narrative
  10196-4Physical findings of Extremities Narrative
  10197-2Physical findings of Eye Narrative
  10198-0Physical findings of Genitourinary tract Narrative
  10199-8Physical findings of Head Narrative
  102-4Cefoperazone [Susceptibility] by Serum bactericidal titer
  1020-7E Ag [Presence] on Red Blood Cells from Donor
  10200-4Physical findings of Heart Narrative
  10201-2Physical findings of Mouth and Throat and Teeth Narrative
  10202-0Physical findings of Nervous system Narrative
  10203-8Physical findings of Nose Narrative
  10204-6Physical findings of Pelvis Narrative
  10205-3Physical findings of Rectum Narrative
  10206-1Physical findings of Skin Narrative
  10207-9Physical findings of Thorax and Lungs Narrative
  10208-7Physical findings of Vessels Narrative
  10209-5Physical findings of Neurologic balance and Coordination Narrative
  1021-5E Ag [Presence] on Red Blood Cells
  10210-3Physical findings of General status Narrative
  10211-1Physical findings of Sense of touch Narrative
  10212-9Physical findings of Strength Narrative
  10213-7Surgical operation note anesthesia Narrative
  10214-5Surgical operation note anesthesia duration
  10215-2Surgical operation note findings Narrative
  10216-0Surgical operation note fluids Narrative
  10217-8Surgical operation note indications [Interpretation] Narrative
  10218-6Surgical operation note postoperative diagnosis Narrative
  10219-4Surgical operation note preoperative diagnosis Narrative
  1022-3Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
  10220-2Surgical operation note prep time duration
  10221-0Surgical operation note specimens taken Narrative
  10222-8Surgical operation note surgical complications [Interpretation] Narrative
  10223-6Surgical operation note surgical procedure Narrative
  10224-4Hemodynamic method special circumstances
  10225-1Cardiac measurement device Institution inventory number
  10226-9Oxygen content in Intravascular space
  10227-7Cardiac measurement device Vendor model number
  10228-5Cardiac measurement device Vendor serial number
  10229-3Hemodynamic method Type of
  1023-1Fy sup(a) Ab [Presence] in Serum or Plasma from Donor
  10230-1Left ventricular Ejection fraction
  10231-9Right ventricular Ejection fraction
  10232-7Oxygen content in Aorta root
  10233-5Oxygen content in Left atrium
  10234-3Oxygen content in Right atrium
  10235-0Oxygen content in High right atrium
  10236-8Oxygen content in Low right atrium
  10237-6Oxygen content in Mid right atrium
  10238-4Oxygen content in Left ventricle
  10239-2Oxygen content in Right ventricular outflow tract
  1024-9Fy sup(a) Ab [Presence] in Serum or Plasma
  10240-0Oxygen content in Right ventricle
  10241-8Oxygen content in Coronary sinus
  10242-6Oxygen content in Ductus arteriosus
  10243-4Oxygen content in Inferior vena cava
  10244-2Oxygen content in Left pulmonary artery
  10245-9Oxygen content in Main pulmonary artery
  10246-7Oxygen content in Right pulmonary artery
  10247-5Oxygen content in Pulmonary wedge
  10248-3Oxygen content in Superior vena cava
  10249-1Heart rate device Institution inventory number
  1025-6Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
  10250-9Heart rate device Vendor model number
  10251-7Heart rate device Vendor serial number
  10252-5Biliary drain site
  10253-3Type of Biliary drain
  10254-1Type of Peritoneal drain
  10255-8Type of Subarachnoid drain
  10256-6Biliary drain Institution inventory number
  10257-4Chest tube Institution inventory number
  10258-2Enteral tube Institution inventory number
  10259-0Gastrostomy tube Institution inventory number
  1026-4Fy sup(a) Ag [Presence] on Red Blood Cells from Donor
  10260-8GI tube Institution inventory number
  10261-6Intravascular tube Institution inventory number
  10262-4IO tube Institution inventory number
  10263-2Nasogastric tube Institution inventory number
  10264-0Oral tube Institution inventory number
  10265-7Peritoneal drain Institution inventory number
  10266-5Peritoneal tube Institution inventory number
  10267-3Rate control device Institution inventory number
  10268-1Stool collection device Institution inventory number
  10269-9Subarachnoid drain Institution inventory number
  1027-2Fy sup(a) Ag [Presence] on Red Blood Cells
  10270-7Synovial drain Institution inventory number
  10271-5Tube or drain Institution inventory number
  10272-3Upper GI tube Institution inventory number
  10273-1Bladder irrigation tube Institution inventory number
  10274-9Urine tube Institution inventory number
  10275-6Wound drain device Institution inventory number
  10276-4Peritoneal drain site
  10277-2Stool collection site
  10278-0Subarachnoid drain site
  10279-8Biliary drain Vendor model number
  1028-0Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit
  10280-6Chest tube Vendor model number
  10281-4Enteral tube Vendor model number
  10282-2Gastrostomy tube Vendor model number
  10283-0GI tube Vendor model number
  10284-8Intravascular tube Vendor model number
  10285-5IO tube Vendor model number
  10286-3Nasogastric tube Vendor model number
  10287-1Oral tube Vendor model number
  10288-9Peritoneal drain Vendor model number
  10289-7Peritoneal tube Vendor model number
  1029-8Fy sup(b) Ab [Presence] in Serum or Plasma from Donor
  10290-5Rate control device Vendor model number
  10291-3Stool collection device Vendor model number
  10292-1Subarachnoid drain Vendor model number
  10293-9Synovial drain Vendor model number
  10294-7Tube or drain Vendor model number
  10295-4Upper GI tube Vendor model number
  10296-2Bladder irrigation tube Vendor model number
  10297-0Urine tube Vendor model number
  10298-8Wound drain device Vendor model number
  10299-6Biliary drain Vendor serial number
  103-2Ceforanide [Susceptibility] by Minimum lethal concentration (MLC)
  1030-6Fy sup(b) Ab [Presence] in Serum or Plasma
  10300-2Chest tube Vendor serial number
  10301-0Enteral tube Vendor serial number
  10302-8Gastrostomy tube Vendor serial number
  10303-6GI tube Vendor serial number
  10304-4Intravascular tube Vendor serial number
  10305-1IO tube Vendor serial number
  10306-9Nasogastric tube Vendor serial number
  10307-7Oral tube Vendor serial number
  10308-5Peritoneal drain Vendor serial number
  10309-3Peritoneal tube Vendor serial number
  1031-4Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit
  10310-1Rate control device Vendor serial number
  10311-9Stool collection device Vendor serial number
  10312-7Subarachnoid drain Vendor serial number
  10313-5Synovial drain Vendor serial number
  10314-3Tube or drain Vendor serial number
  10315-0Upper GI tube Vendor serial number
  10316-8Bladder irrigation tube Vendor serial number
  10317-6Urine tube Vendor serial number
  10318-4Wound drain device Vendor serial number
  10319-2Enema device Institution inventory number
  1032-2Fy sup(b) Ag [Presence] on Red Blood Cells from Donor
  10320-0Enema device Vendor model number
  10321-8Enema device Vendor serial number
  10322-6Potassium intake 24 hour
  10323-4Wound drain fluid [Appearance] Lower GI tract
  10324-2Breath rate device Institution inventory number
  10325-9Breath rate device Vendor model number
  10326-7Breath rate device Vendor serial number
  10327-5Eosinophils/100 leukocytes in Sputum by Manual count
  10328-3Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count
  10329-1Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count
  1033-0Fy sup(b) Ag [Presence] on Red Blood Cells
  10330-9Monocytes/100 leukocytes in Body fluid by Manual count
  10331-7Rh [Type] in Blood
  10332-5Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM
  10333-3Appearance of Cerebral spinal fluid
  10334-1Cancer Ag 125 [Units/volume] in Serum or Plasma
  10335-8Color of Cerebral spinal fluid
  10336-6Gonadotropin peptide [Mass/volume] in Urine
  10337-4Procollagen type I [Mass/volume] in Serum
  10338-2Barbiturates [Mass/volume] in Serum or Plasma
  10339-0FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma
  1034-8Fetal cell screen [Interpretation] in Blood
  10340-8Molindone [Mass/volume] in Serum or Plasma
  10341-6Norpropoxyphene [Mass/volume] in Serum or Plasma
  10342-4Sulfamethoxazole [Mass/volume] in Serum or Plasma
  10343-2Temazepam [Mass/volume] in Serum or Plasma
  10344-0Tranylcypromine [Mass/volume] in Serum or Plasma
  10345-7Trihexyphenidyl [Mass/volume] in Urine
  10346-5Hemoglobin A [Units/volume] in Blood by Electrophoresis
  10347-3Babesia microti identified in Blood by Light microscopy
  10348-1Bordetella parapertussis Ab [Presence] in Serum
  10349-9Brucella sp Ab [Units/volume] in Serum
  1035-5Fresh frozen plasma given [Volume]
  10350-7Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay
  10351-5HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
  10352-3Bacteria identified in Genital specimen by Aerobe culture
  10353-1Bacteria identified in Nose by Aerobe culture
  10354-9Bacteria identified in Urethra by Culture
  10355-6Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain
  10356-4Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain
  10357-2Microscopic observation [Identifier] in Wound by Gram stain
  10358-0Teichoate Ab [Titer] in Serum by Immune diffusion (ID)
  10359-8Asialoganglioside GM1 IgM Ab [Titer] in Serum
  1036-3G Ab [Presence] in Serum or Plasma from Blood product unit
  10360-6DNA single strand IgG Ab [Units/volume] in Serum
  10361-4DNA single strand IgM Ab [Units/volume] in Serum
  10362-2Endomysium IgA Ab [Presence] in Serum
  10363-0Barbiturates [Presence] in Specimen
  10364-8Cotinine [Mass/mass] in Hair
  10365-5Cotinine [Mass/volume] in Serum or Plasma
  10366-3Cotinine [Mass/volume] in Urine
  10367-1Ethanol [Mass/volume] in Gastric fluid
  10368-9Lead [Mass/volume] in Capillary blood
  10369-7Opiates [Mass/mass] in Hair
  1037-1G Ab [Presence] in Serum or Plasma from Donor
  10370-5Phencyclidine [Mass/mass] in Hair
  10371-3Bite cells [Presence] in Blood by Light microscopy
  10372-1Blister cells [Presence] in Blood by Light microscopy
  10373-9Fragments [Presence] in Blood by Light microscopy
  10374-7Helmet cells [Presence] in Blood by Light microscopy
  10375-4Irregularly contracted cells [Presence] in Blood by Light microscopy
  10376-2Oval macrocytes [Presence] in Blood by Light microscopy
  10377-0Pencil cells [Presence] in Blood by Light microscopy
  10378-8Polychromasia [Presence] in Blood by Light microscopy
  10379-6Erythrocytes.dual population [Presence] in Blood by Light microscopy
  1038-9G Ab [Presence] in Serum or Plasma
  10380-4Stomatocytes [Presence] in Blood by Light microscopy
  10381-2Target cells [Presence] in Blood by Light microscopy
  10382-0Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit
  10383-8Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells from Donor
  10384-6Deprecated A,B variant NOS Ag [Presence] on Red Blood Cells
  10385-3Albumin concentration given
  10386-1Albumin given [Volume]
  10387-9Autologous erythrocytes given [Volume]
  10388-7Autologous whole blood given [Volume]
  10389-5Blood product.other [Type]
  1039-7G Ag [Presence] on Red Blood Cells from Blood product unit
  10390-3Blood product special preparation [Type]
  10391-1Cytomegalovirus immune globulin given [Volume]
  10392-9Cryoprecipitate given [Volume]
  10393-7Factor IX given [Type]
  10394-5Factor IX given [Volume]
  10395-2Factor VIII given [Type]
  10396-0Factor VIII given [Volume]
  10397-8Hepatitis B immune globulin given [Volume]
  10398-6I Ag [Presence] on Red Blood Cells from Blood product unit
  10399-4I Ag [Presence] on Red Blood Cells from Donor
  104-0Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC)
  1040-5G Ag [Presence] on Red Blood Cells from Donor
  10400-0I Ag [Presence] on Red Blood Cells
  10401-8Immune serum globulin given [Type]
  10402-6Immune serum globulin given [Volume]
  10403-4Inject immune serum globulin [Volume]
  10404-2Inject Rh immune globulin [Volume]
  10405-9Inject varicella zoster virus immune globulin [Volume]
  10406-7little i Ag [Presence] on Red Blood Cells from Blood product unit
  10407-5little i Ag [Presence] on Red Blood Cells from Donor
  10408-3little i Ag [Presence] on Red Blood Cells
  10409-1Pentaspan given [Volume]
  1041-3G Ag [Presence] on Red Blood Cells
  10410-9Plasma given [Type]
  10411-7Plasma given [Volume]
  10412-5Platelets given [Type]
  10413-3Rh immune globulin given [Volume]
  10414-1Transfuse albumin [Volume]
  10415-8Transfuse blood exchange transfusion [Volume]
  10416-6Transfuse blood product other [Volume]
  10417-4Transfuse cryoprecipitate [Volume]
  10418-2Transfuse factor IX [Volume]
  10419-0Transfuse factor VIII [Volume]
  1042-1H Ab [Presence] in Serum or Plasma from Blood product unit
  10420-8Transfuse immune serum globulin [Volume]
  10421-6Transfuse Pentaspan [Volume]
  10422-4Transfuse plasma [Volume]
  10423-2Transfuse platelets [Volume]
  10424-0Transfuse erythrocytes [Volume]
  10425-7Transfuse Rh immune globulin [Volume]
  10426-5Transfuse whole blood [Volume]
  10427-3Transfuse whole blood autologous [Volume]
  10428-1Varicella zoster virus immune globulin given [Volume]
  10429-9AE 1 Ag [Presence] in Tissue by Immune stain
  1043-9H Ab [Presence] in Serum or Plasma from Donor
  10430-7AE 3 Ag [Presence] in Tissue by Immune stain
  10431-5B-cell Ag [Presence] in Tissue by Immune stain
  10432-3CD30 Ag [Presence] in Tissue by Immune stain
  10433-1BR-2 Ag [Presence] in Tissue by Immune stain
  10434-9Complement C3 Ag [Presence] in Tissue by Immune stain
  10435-6C5B-9 Ag [Presence] in Tissue by Immune stain
  10436-4CD15 Ag [Presence] in Tissue by Immune stain
  10437-2CD16 Ag [Presence] in Tissue by Immune stain
  10438-0CD20 Ag [Presence] in Tissue by Immune stain
  10439-8CD3 Ag [Presence] in Tissue by Immune stain
  1044-7H Ab [Presence] in Serum
  10440-6Deprecated CD30 Ag [Presence] in Tissue by Immune stain
  10441-4CD34 Ag [Presence] in Tissue by Immune stain
  10442-2CD56 Ag [Presence] in Tissue by Immune stain
  10443-0CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain
  10444-8CD57 Ag [Presence] in Tissue by Immune stain
  10445-5CD11c Ag [Presence] in Tissue by Immune stain
  10446-3Leukocyte common Ag [Presence] in Tissue by Immune stain
  10447-1M-5 Ag [Presence] in Tissue by Immune stain
  10448-9T-cell Ag [Presence] in Tissue by Immune stain
  10449-7Glucose [Mass/volume] in Serum or Plasma --1 hour post meal
  1045-4Deprecated H NOS Ab [Presence] in Serum or Plasma from Blood product unit
  10450-5Glucose [Mass/volume] in Serum or Plasma --10 hours fasting
  10451-3Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting
  10452-1Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO
  10453-9Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO
  10454-7Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO
  10455-4Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO
  10456-2Xylose [Mass/volume] in Serum or Plasma --6 hours fasting
  10457-0Actin Ag [Presence] in Tissue by Immune stain
  10458-8Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain
  10459-6Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain
  1046-2Deprecated H NOS Ab [Presence] in Serum or Plasma from Donor
  10460-4Lactalbumin alpha Ag [Presence] in Tissue by Immune stain
  10461-2Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain
  10462-0Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain
  10463-8Amyloid A component Ag [Presence] in Tissue by Immune stain
  10464-6Amyloid P component Ag [Presence] in Tissue by Immune stain
  10465-3Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain
  10466-1Anion gap 3 in Serum or Plasma
  10467-9Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain
  10468-7Calcitonin Ag [Presence] in Tissue by Immune stain
  10469-5Carcinoembryonic Ag [Presence] in Tissue by Immune stain
  1047-0Deprecated H NOS Ab [Presence] in Serum or Plasma
  10470-3Choriogonadotropin Ag [Presence] in Tissue by Immune stain
  10471-1Chromogranin A Ag [Presence] in Tissue by Immune stain
  10472-9Chromogranin Ag [Presence] in Tissue by Immune stain
  10473-7Chymotrypsin Ag [Presence] in Tissue by Immune stain
  10474-5Collagen type 4 Ag [Presence] in Tissue by Immune stain
  10475-2Corticotropin Ag [Presence] in Tissue by Immune stain
  10476-0Desmin Ag [Presence] in Tissue by Immune stain
  10477-8Enolase.neuron specific Ag [Presence] in Tissue by Immune stain
  10478-6Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain
  10479-4CD227 Ag [Presence] in Tissue by Immune stain
  1048-8Deprecated H NOS Ag [Presence] on Red Blood Cells from Blood product unit
  10480-2Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain
  10481-0Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain
  10482-8Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain
  10483-6Gastrin Ag [Presence] in Tissue by Immune stain
  10484-4Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain
  10485-1Glucagon Ag [Presence] in Tissue by Immune stain
  10486-9Hemoglobin Ag [Presence] in Tissue by Immune stain
  10487-7HMB-45 Ag [Presence] in Tissue by Immune stain
  10488-5IgA Ag [Presence] in Tissue by Immune stain
  10489-3IgA.heavy chain Ag [Presence] in Tissue by Immune stain
  1049-6Deprecated H NOS Ag [Presence] on Red Blood Cells from Donor
  10490-1IgE Ag [Presence] in Tissue by Immune stain
  10491-9IgG Ag [Presence] in Tissue by Immune stain
  10492-7IgG.heavy chain Ag [Presence] in Tissue by Immune stain
  10493-5IgM Ag [Presence] in Tissue by Immune stain
  10494-3IgM.heavy chain Ag [Presence] in Tissue by Immune stain
  10495-0Insulin Ag [Presence] in Tissue by Immune stain
  10496-8Kappa light chains Ag [Presence] in Tissue by Immune stain
  10497-6Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain
  10498-4Keratin Ag [Presence] in Tissue by Immune stain
  10499-2Lambda light chains Ag [Presence] in Tissue by Immune stain
  105-7Ceforanide [Susceptibility] by Disk diffusion (KB)
  1050-4Deprecated H NOS Ag [Presence] on Red Blood Cells
  10500-7Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain
  10501-5Lutropin [Units/volume] in Serum or Plasma
  10502-3Lutropin Ag [Presence] in Tissue by Immune stain
  10503-1Lysozyme Ag [Presence] in Tissue by Immune stain
  10504-9Myelin basic protein Ag [Presence] in Tissue by Immune stain
  10505-6Myoglobin Ag [Presence] in Tissue by Immune stain
  10506-4Peanut agglutinin Ag [Presence] in Tissue by Immune stain
  10507-2Prolactin Ag [Presence] in Tissue by Immune stain
  10508-0Prostate specific Ag [Presence] in Tissue by Immune stain
  10509-8Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain
  1051-2Hemolytic disease of newborn screen [Interpretation] in Blood
  10510-6S-100 Ag [Presence] in Tissue by Immune stain
  10511-4Serotonin Ag [Presence] in Tissue by Immune stain
  10512-2Somatostatin Ag [Presence] in Tissue by Immune stain
  10513-0Somatotropin Ag [Presence] in Tissue by Immune stain
  10514-8Synaptophysin Ag [Presence] in Tissue by Immune stain
  10515-5Thyroglobulin Ag [Presence] in Tissue by Immune stain
  10516-3Thyrotropin Ag [Presence] in Tissue by Immune stain
  10517-1Trypsin Ag [Presence] in Tissue by Immune stain
  10518-9Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain
  10519-7Vimentin Ag [Presence] in Tissue by Immune stain
  1052-0Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit
  10520-5Coagulation factor VI Ag [Presence] in Tissue by Immune stain
  10521-3Coagulation factor VIII Ag [Presence] in Tissue by Immune stain
  10522-1Coagulation factor XIII Ag [Presence] in Tissue by Immune stain
  10523-9Fibrinogen Ag [Presence] in Tissue by Immune stain
  10524-7Microscopic observation [Identifier] in Cervix by Cyto stain
  10525-4Microscopic observation [Identifier] in Specimen by Cyto stain
  10526-2Microscopic observation [Identifier] in Sputum by Cyto stain
  10527-0Microscopic observation [Identifier] in Tissue by Cyto stain
  10528-8Acetophenazine [Mass/volume] in Serum or Plasma
  10529-6Amoxapine metabolite [Mass/volume] in Serum or Plasma
  1053-8Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor
  10530-4Aprobarbital [Mass/volume] in Serum or Plasma
  10531-2Bretylium [Mass/volume] in Serum or Plasma
  10532-0Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma
  10533-8Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma
  10534-6Diazoxide [Mass/volume] in Serum or Plasma
  10535-3Digoxin [Mass/volume] in Serum or Plasma
  10536-1Dipyridamole [Mass/volume] in Serum or Plasma
  10537-9Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma
  10538-7Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma
  10539-5glipiZIDE [Mass/volume] in Serum or Plasma
  1054-6Deprecated I (intermediate) subtype [Presence] in srum
  10540-3glyBURIDE [Mass/volume] in Serum or Plasma
  10541-1Mepivacaine [Mass/volume] in Serum or Plasma
  10542-9Metharbital [Mass/volume] in Serum or Plasma
  10543-7Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma
  10544-5Normeperidine [Presence] in Serum or Plasma
  10545-2Normephenytoin [Mass/volume] in Serum or Plasma
  10546-0Normethsuximide [Mass/volume] in Serum or Plasma
  10547-8Primidone+PHENobarbital [Mass/volume] in Serum or Plasma
  10548-6Phenytoin Free/Phenytoin.total in Serum or Plasma
  10549-4Pirmenol [Mass/volume] in Serum or Plasma
  1055-3Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit
  10550-2Deprecated Temazepam [Mass/volume] in Serum or Plasma
  10551-0Triamterene [Mass/volume] in Serum or Plasma
  10552-8Tricyclic antidepressants [Mass/volume] in Serum or Plasma
  10553-6Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid
  10554-4Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma
  10555-1Acrosin [Entitic Catalytic Activity] in Spermatozoa
  10556-9Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma
  10557-7Adenosine triphosphate [Moles/volume] in Semen
  10558-5Albumin [Moles/volume] in Semen
  10559-3Deprecated Calcium [Molecules/volume] in Semen
  1056-1Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor
  10560-1Carcinoembryonic Ag [Units/volume] in Semen
  10561-9Carnitine [Moles/volume] in Semen
  10562-7Cells [#/volume] in Cervical mucus
  10563-5Cells other than spermatozoa [#/volume] in Semen
  10564-3Cervical mucus [Volume]
  10565-0Choriogonadotropin [Units/volume] in Semen
  10566-8Deprecated Choriogonadotropin [Molecules/volume] in Semen
  10567-6Citrate [Moles/volume] in Semen
  10568-4Clarity of Semen
  10569-2Color of Semen
  1057-9Deprecated I (intermediate) subtype [Presence] on Red Blood Cells
  10570-0Consistency of Cervical mucus
  10571-8Deprecated Consistency of Semen
  10572-6Deprecated Duration^post ejaculation
  10573-4Ferning [Type] in Cervical mucus
  10574-2Fructose [Moles/volume] in Semen
  10575-9Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen
  10576-7Germ cells.immature [#/volume] in Semen
  10577-5Glucosidase [Enzymatic activity/volume] in Seminal plasma
  10578-3Glycerophosphocholine [Moles/volume] in Seminal plasma
  10579-1Leukocytes [#/volume] in Semen
  1058-7I Ab [Presence] in Serum or Plasma from Blood product unit
  10580-9Liquefaction [Time] in Semen
  10581-7Deprecated Number of entities [#] in Spermatozoa
  10582-5pH of Cervical mucus
  10583-3Prostaglandin F1 alpha [Moles/volume] in Semen
  10584-1Deprecated Protein [Mass/volume] in Semen
  10585-8Round cells [#/volume] in Semen
  10586-6Deprecated Volume of Semen
  10587-4Sexual abstinence duration
  10588-2Spermatogonia [#/volume] in Semen
  10589-0Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB)
  1059-5I Ab [Presence] in Serum or Plasma from Donor
  10590-8Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB)
  10591-6Primary Spermatocytes [#/volume] in Semen
  10592-4Secondary Spermatocytes [#/volume] in Semen
  10593-2Spermatozoa Pyriform Head/100 spermatozoa in Semen
  10594-0Spermatozoa Tapering Head/100 spermatozoa in Semen
  10595-7Deprecated Spermatozoa [#/volume] in Semen
  10596-5Deprecated Spermatozoa Ab in cervical mucosa
  10597-3Deprecated Spermatozoa Ab in semen
  10598-1Deprecated Spermatozoa Ab in serum
  10599-9Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test
  106-5Ceforanide [Susceptibility] by Serum bactericidal titer
  1060-3I Ab [Presence] in Serum or Plasma
  10600-5Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa
  10601-3Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus
  10602-1Spermatozoa Abnormal Head/100 spermatozoa in Semen
  10603-9Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen
  10604-7Spermatozoa Abnormal Tail/100 spermatozoa in Semen
  10605-4Spermatozoa Agglutinated/100 spermatozoa in Semen
  10606-2Spermatozoa Amorphous Head/100 spermatozoa in Semen
  10607-0Spermatozoa Coiled Tail/100 spermatozoa in Semen
  10608-8Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen
  10609-6Spermatozoa Duplicate Head/100 spermatozoa in Semen
  1061-1Deprecated I NOS Ab [Presence] in Serum or Plasma from Blood product unit
  10610-4Spermatozoa Duplicate Tail/100 spermatozoa in Semen
  10611-2Spermatozoa Immotile/100 spermatozoa in Semen
  10612-0Spermatozoa Large Oval Head/100 spermatozoa in Semen
  10613-8Spermatozoa Viable/100 spermatozoa in Semen
  10614-6Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead
  10615-3Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction
  10616-1Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead
  10617-9Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction
  10618-7Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead
  10619-5Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction
  1062-9Deprecated I NOS Ab [Presence] in Serum or Plasma from Donor
  10620-3Spermatozoa Nonprogressive/100 spermatozoa in Semen
  10621-1Spermatozoa Normal Head/100 spermatozoa in Semen
  10622-9Spermatozoa Normal/100 spermatozoa in Semen
  10623-7Spermatozoa Pin Head/100 spermatozoa in Semen
  10624-5Spermatozoa Rapid/100 spermatozoa in Semen
  10625-2Spermatozoa Round Head/100 spermatozoa in Semen
  10626-0Spermatozoa Slow/100 spermatozoa in Semen
  10627-8Spermatozoa Small Oval Head/100 spermatozoa in Semen
  10628-6Spermatozoa Tail Swelling/100 spermatozoa in Semen
  10629-4Spermatozoa Vacuolated Head/100 spermatozoa in Semen
  1063-7Deprecated I NOS Ab [Presence] in Serum or Plasma
  10630-2Spinnbarkeit [Length] in Cervical mucus
  10631-0Testosterone [Moles/volume] in Semen
  10632-8Time until next menstrual period
  10633-6Zinc [Moles/volume] in Semen
  10634-4Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
  10635-1Acanthamoeba sp identified in Eye by Organism specific culture
  10636-9Acanthamoeba sp identified in Eye by Wet preparation
  10637-7Microscopic observation [Identifier] in Tissue by Night blue stain
  10638-5Thermophilic Actinomycetes colony count [#/volume] in Specimen by Organism specific culture
  10639-3Thermophilic Actinomycetes identified in Specimen by Organism specific culture
  1064-5Deprecated I NOS Ag [Presence] on Red Blood Cells from Blood product unit
  10640-1Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy
  10641-9Amoeba identified in Aspirate by Immune stain
  10642-7Amoeba identified in Aspirate by Wet preparation
  10643-5Amoeba identified in Stool by Organism specific culture
  10644-3Arthropod identified in Specimen
  10645-0Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence
  10646-8Astrovirus [Identifier] in Stool by Electron microscopy
  10647-6Babesia sp identified in Blood by Thick film
  10648-4Babesia sp identified in Blood by Thin film
  10649-2Calicivirus [Identifier] in Stool by Electron microscopy
  1065-2Deprecated I NOS Ag [Presence] on Red Blood Cells from Donor
  10650-0Candida sp DNA [Presence] in Blood by Probe with amplification
  10651-8Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial
  10652-6Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification
  10653-4Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC)
  10654-2Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC)
  10655-9Coccidia identified in Duodenal fluid by Acid fast stain
  10656-7Coccidia identified in Stool by Acid fast stain
  10657-5Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence
  10658-3Cyanobacterium identified in Water by Light microscopy
  10659-1Cyclospora sp identified in Stool by Acid fast stain
  1066-0Deprecated I NOS Ag [Presence] on Red Blood Cells
  10660-9Cytomegalovirus Ag [Presence] in Tissue by Immune stain
  10661-7Dinoflagellate identified in Water by Light microscopy
  10662-5Filaria identified in Blood by Concentration
  10663-3Filaria identified in Blood by Thick film
  10664-1Filaria identified in Blood by Thin film
  10665-8Fungus colony count [#/volume] in Specimen by Environmental culture
  10666-6Fungus identified in Tissue by Fontana-Masson stain
  10667-4Fungus identified in Specimen by Animal inoculation
  10668-2Fungus identified in Specimen by Environmental culture
  10669-0Fungus identified in Specimen by Sticky tape for environmental fungus
  1067-8Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit
  10670-8Giardia lamblia [Presence] in Stool by Organism specific culture
  10671-6Helminth identified in Specimen
  10672-4Helminth+Arthropod identified in Specimen
  10673-2Hepatitis B virus core Ag [Presence] in Tissue by Immune stain
  10674-0Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain
  10675-7Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain
  10676-5Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
  10677-3Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain
  10678-1Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain
  10679-9Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain
  1068-6Jk sup(a) Ab [Presence] in Serum or Plasma from Donor
  10680-7Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy
  10681-5Herpes simplex virus identified in Tissue by Electron microscopy
  10682-3Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification
  10683-1Hydatid cyst identified in Aspirate by Immune stain
  10684-9Hydatid cyst identified in Liver by Wet preparation
  10685-6Hydatid cyst identified in Lung tissue by Wet preparation
  10686-4Leishmania sp identified in Tissue by Giemsa stain
  10687-2Leishmania sp identified in Tissue by Organism specific culture
  10688-0Microscopic observation [Identifier] in Hair by KOH preparation
  10689-8Microscopic observation [Identifier] in Nail by KOH preparation
  1069-4Jk sup(a) Ab [Presence] in Serum or Plasma
  10690-6Microsporidia identified in Duodenal fluid by Trichrome stain modified
  10691-4Mushroom.toxic identified by Inspection
  10692-2Mushroom.toxic identified in Food by Light microscopy
  10693-0Mushroom.toxic identified in Vomitus by Light microscopy
  10694-8Naegleria sp identified in Tissue by Organism specific culture
  10695-5Naegleria sp identified in Tissue by Wet preparation
  10696-3Norovirus [Identifier] in Stool by Electron microscopy
  10697-1Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC)
  10698-9Nystatin [Susceptibility] by Minimum lethal concentration (MLC)
  10699-7Onchocerca sp identified in Tissue by Wet preparation
  107-3Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC)
  1070-2Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit
  10700-3Orthopoxvirus [Identifier] in Skin by Electron microscopy
  10701-1Ova and parasites identified in Stool by Concentration
  10702-9Ova and parasites identified in Stool by Immune stain
  10703-7Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain
  10704-5Ova and parasites identified in Stool by Light microscopy
  10705-2Human papilloma virus Ag [Presence] in Tissue by Immune stain
  10706-0Picornavirus [Identifier] in Stool by Electron microscopy
  10707-8Toxic Plant identified in Plant specimen by Inspection
  10708-6Toxic Plant identified in Vomitus by Light microscopy
  10709-4Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence
  1071-0Jk sup(a) Ag [Presence] on Red Blood Cells from Donor
  10710-2Plasmodium sp identified in Blood by Thin film
  10711-0Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence
  10712-8Pneumocystis sp identified in Lung tissue
  10713-6Prototheca identified in Specimen by Culture
  10714-4Deprecated Rotavirus [Identifier] in Stool by Electron microscopy
  10715-1Schistosoma sp identified in Urine sediment by Light microscopy
  10716-9Schistosoma sp identified in Specimen by Organism specific culture
  10717-7Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination
  10718-5Strongyloides sp Ab [Units/volume] in Serum by Immunoassay
  10719-3Taenia solium adult Ab [Units/volume] in Serum by Immunoblot
  1072-8Jk sup(a) Ag [Presence] on Red Blood Cells
  10720-1Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC)
  10721-9Terbinafine [Susceptibility] by Minimum lethal concentration (MLC)
  10722-7Torovirus [Identifier] in Stool by Electron microscopy
  10723-5Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay
  10724-3Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay
  10725-0Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification
  10726-8Toxoplasma gondii [Presence] in Tissue by Giemsa stain
  10727-6Toxoplasma gondii identified in Tissue
  10728-4Trichomonas sp identified in Genital specimen by Organism specific culture
  10729-2Trypanosoma sp identified in Blood by Light microscopy
  1073-6Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit
  10730-0Trypanosoma sp identified in Blood by Organism specific culture
  10731-8Trypanosoma sp identified in Blood by Thick film
  10732-6Trypanosoma sp identified in Blood by Thin film
  10733-4Trypanosoma sp identified in Blood by Wet preparation
  10734-2Varicella zoster virus identified in Skin by Electron microscopy
  10735-9Viral sequencing [Identifier] in Serum by Sequencing
  10736-7Virus identified in Cerebral spinal fluid by Electron microscopy
  10737-5Virus identified in Stool by Electron microscopy
  10738-3Virus identified in Tissue by Electron microscopy
  10739-1Virus identified in Specimen by Electron microscopy
  1074-4Jk sup(b) Ab [Presence] in Serum or Plasma from Donor
  10740-9Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain
  10741-7Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain
  10742-5Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified
  10743-3Amyloid.microscopic observation [Identifier] in Tissue by Highman stain
  10744-1Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain
  10745-8Bile.microscopic observation [Identifier] in Tissue by Fouchet stain
  10746-6Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain
  10747-4Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain
  10748-2Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain
  10749-0Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain
  1075-1Jk sup(b) Ab [Presence] in Serum or Plasma
  10750-8Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson
  10751-6Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain
  10752-4Fat.microscopic observation [Identifier] in Milk by Sudan IV stain
  10753-2Fat.microscopic observation [Identifier] in Stool by Sudan IV stain
  10754-0Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain
  10755-7Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott
  10756-5Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain
  10757-3Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code

History

DateActionAuthorCustodianComment
2020-05-06reviseTed KleinVocabulary WGMigrated to the UTG maintenance environment and publishing tooling.